Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study [PLoS Med Sept 2020]
Posted byTerri Fettinger
This is a widget ready area. Add some and they will appear here.
